Is Aurora Cannabis Inc. (TSX:ACB) Stock Still Oversold?

Aurora Cannabis (TSX:ACB) (NYSE:ACB) is catching a nice tailwind after a nasty drop through the end of 2018. Is more upside on the way?

| More on:

Marijuana stocks are enjoying a new rally and investors who stayed on the sidelines through the downturn at the end of 2018 are wondering which pot stocks might be the best buys right now.

Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) to see if it deserves to be in your portfolio today.

Acquisitions

Aurora Cannabis has been one of the more aggressive players in the Canadian marijuana market. The company made two major acquisitions in 2018 that consolidated the space and launched Aurora Cannabis into the big leagues among other large players such as Canopy Growth and Tilray.

The deals, which included the $2.5 billion takeover of MedReleaf in July and the $1.1 billion purchase of CanniMed in January, gave Aurora important production capacity and broader geographic coverage for both the Canadian medical marijuana market and the recently launched recreational market.

Aurora is continuing to grow in 2019. The company just announced a $175 million agreement to acquire Whistler Medical Marijuana. The deal adds production facilities in British Columbia, as well as a portfolio of premium products.

Overseas

Aurora also has its sights on a number of international opportunities, including Europe. The company is building a one million square foot greenhouse in Denmark with operations in Germany to serve the growing European medical marijuana market.

Diversified businesses

Aurora’s portfolio of companies includes investments in areas where cannabis products are expected to expand. The company has a 25% interest in Alcanna, the largest private sector alcohol retailer in Canada.

In the cosmetics segment, Aurora has a partnership with Envio Beauty to develop and market hemp seed oil and CBD-based lifestyle products.

The medical opportunities are also in the company’s sights. Aurora has a small ownership position in CTT Pharmaceuticals, which provides innovative drug delivery systems for pain treatment.

Finally, the sale of cannabis edibles is expected to be legalized in Canada at some point in 2019. Aurora has a majority interest in Hempco Food and Fiber, a hemp-based food company with more than a decade of experience in the sector.

Should you buy?

Aurora Cannabis currently trades at $9.60 per share, giving the company a market capitalization of about $9.6 billion. This provides management with the financial clout to continue to grow, and it wouldn’t be a surprise to see Aurora take a run at Aphria or HEXO in 2019.

HEXO, in particular, might be an attractive target, as it would give Aurora a stronger presence in Quebec and also put it in a leadership position in the infused-drinks segment through the Truss partnership with Molson Coors Canada.

The stock is up significantly in the past week, but still sits well below the $15 peak it reached last year. I wouldn’t back up the truck, but Aurora might be an interesting pick today for investors who expect the marijuana sector to take off in the coming years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

A worker uses a laptop inside a restaurant.
Tech Stocks

This E-Commerce Stock Could Be a Better Growth Play Than Amazon

Let's dive into a rather intriguing thesis that Shopify (TSX:SHOP) could be a better growth stock than Amazon (NASDAQ:AMZN) from…

Read more »

profit rises over time
Dividend Stocks

A Dividend Giant I’d Buy Over TD Stock Right Now

TD stock has long been one of the top dividend stocks for investors to consider, but that's simply no longer…

Read more »

ways to boost income
Energy Stocks

Act Fast: These 2 Canadian Energy Stocks Are Must-Buys Before Year-End

Here are two high-potential Canadian energy stocks with stable dividends you can consider adding to your portfolio before the year…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Investing

Should You Buy the Post-Earnings Dip in Dollarama Stock?

Following positive Q3 numbers and future growth prospects, should investors accumulate stock in this popular retailer on the pullback to…

Read more »

analyze data
Dividend Stocks

Top Financial Sector Stocks for Canadian Investors in 2025

From undervalued to powerfully bullish, quite a few financial stocks might be promising prospects for the coming year.

Read more »

Canada national flag waving in wind on clear day
Dividend Stocks

3 TFSA Red Flags Every Canadian Investor Should Know

Day trading in a TFSA is a red flag. Hold index funds like the Vanguard S&P 500 Index Fund (TSX:VFV)…

Read more »

sale discount best price
Stocks for Beginners

Have $2,000? These 2 Stocks Could Be Bargain Buys for 2025 and Beyond

Fairfax Financial Holdings (TSX:FFH) and another bargain buy are fit for new Canadian investors.

Read more »

Rocket lift off through the clouds
Stocks for Beginners

2 Canadian Growth Stocks Set to Skyrocket in the Next 12 Months

Despite delivering disappointing performance in 2024, these two cheap Canadian growth stocks could offer massive upside in 2025.

Read more »